GLP-1 RAs May Ease Psoriasis, PsA Data Limited - Top-Institutions - MDSpire

GLP-1 RAs May Ease Psoriasis, PsA Data Limited

Published evidence linked liraglutide and semaglutide to improvements in psoriasis severity, inflammatory markers, and metabolic outcomes, while evidence in psoriatic arthritis remained sparse.

  • By

  • Andrea Surnit

  • June 27, 2026

  • 4 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    University of Modena
    University of Modena

    Modena, Emilia-Romagna

    Key Differentiators

    • Dermatology

  • #2

    National Psoriasis Foundation Medical Board
    National Psoriasis Foundation Medical Board

    Portland, Oregon

    Key Differentiators

    • Dermatology

  • #3

    Cole Eye Institute, Cleveland Clinic
    Cole Eye Institute, Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Ophthalmology
    • Dermatology

  • #4

    Case Western Reserve University
    Case Western Reserve University

    Cleveland, Ohio

    Key Differentiators

    • Dermatology

  • #5

    MetroHealth Hospital
    MetroHealth Hospital

    Cleveland, Ohio

    Key Differentiators

    • Dermatology

Original Source(s)

GLP-1 RAs May Ease Psoriasis, PsA Data Limited

  • by Andrea Surnit

  • June 27, 2026

Related Content

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

Restorative Management of Constriction and Spacing Following Arch Expansion

MiR-1a-3p/Fcgr4-dependent osteoclast activation regulates pathological bone loss